Complications of presumed ocular tuberculosis

Acta Ophthalmologica

Volumn 88, Issue 8, 2010, Pages 905-909

  Hamade, Issam H ^a   Tabbara, Khalid F ^a,b,c  

^a The Eye Foundation for Research in Ophthalmology   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

corticosteroids; ocular inflammation; posterior uveitis; PPD; presumed ocular tuberculosis; uveitis

Indexed keywords

CORTICOSTEROID; CYCLOPLEGIC AGENT; ETHAMBUTOL; ISONIAZID; POSITIVE PURIFIED PROTEIN DERIVATIVE; PREDNISONE; PROTEIN DERIVATIVE; PYRAZINAMIDE; RIFAMPICIN; TRIAMCINOLONE ACETONIDE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; CATARACT; CHILD; CHORIORETINITIS; CHOROIDITIS; COMPARATIVE STUDY; CORNEA DISEASE; CORNEA SCAR; CORTICOSTEROID THERAPY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EYE DISEASE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTERSTITIAL KERATITIS; IRIS DISEASE; IRIS GRANULOMA; MAJOR CLINICAL STUDY; MALE; OCULAR TUBERCULOSIS; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; OUTCOME ASSESSMENT; PAPILLITIS; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA VASCULITIS; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SCLERA DISEASE; SCLEROMALACIA; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULIN TEST; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHORIORETINITIS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUBERCULOSIS, OCULAR; UVEITIS; VISUAL ACUITY; YOUNG ADULT;

EID: 78649859807     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01579.x     Document Type: Review

References (22)

1. Aouama K, Chaabane A, Loussaief C, Ben Romdhane F, Boughattas NA, &, Chakroun M, (2007): Adverse effects of anitubercular drugs: epidemiology, mechanisms, and patient management. Med Mal Infect 37: 253-261.
2. Biswas J, Kumar SK, Rupauliha P, et al. (2002): Detection of mycobacterium tuberculosis by nested polymerase chain reaction in a case of subconjunctival tuberculosis. Cornea 21: 123-125.
3. Bodaghi B, &, LeHoang P, (2000): Ocular tuberculosis. Curr Opin Ophthalmol 11: 443-448.
4. Centers for Disease Control (2000): Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep 49: 1-54.
5. Centers for Disease Control (2003): Treatment of tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 52: RR1.
6. Centers for Disease Control and Prevention (1995): Coincidence of HIV/AIDS and tuberculosis-Chicago 1982-1993. MMWR Morb Mortal Wkly Rep 44: 227-231.
7. Dannenberg AM, (1991): Delayed-type hypersensitivity and cell mediated immunity in the pathogenesis of tuberculosis. Immunol Today 12: 28-33.
8. Gupta V, Gupta A, Sachdeva N, et al. (2006): Successful management of tubercular subretinal granulomas. Ocul Immunol Inflamm 14: 35-40.
9. Gupta V, Gupta A, &, Rao NA, (2007): Intraocular tuberculosis: an update. Am J Ophthalmol 52: 561-587.
10. Hamade IH, Al Shamsi HN, Al Dhibi H, et al. (2009): Uveitis survey in children. Br J Ophthalmol 93: 569-572.
11. Helm CJ, &, Holland GN, (1993): Ocular tuberculosis. Surv Ophthalmol 38: 229-256.
12. Islam SM, &, Tabbara KF, (2002): Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol 9: 239-249.
13. Jabs DA, Nussenblatt RB, Rosenbaum JT, & the Standardization of Uveitis Nomenclature (SUN) Working Group (2005): Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol 140: 509-516.
14. Khanna A, Sidhu U, Bajwa G, &, Malhotra V, (2007): Pattern of ocular manifestations in patients with sarcoidosis in developing countries. Acta Ophthalmol Scand 85: 609-612.
15. Mehta S, &, Gilada IS, (2005): Ocular tuberculosis in acquired immune deficiency syndrome (AIDS). Ocul Immunol Inflamm 13: 87-89.
16. Melamud A, Kosmorsky GS, &, Lee MS, (2003): Ocular ethambutol toxicity. Mayo Clin Proc 78: 1409-1411.
17. Morimura Y, Okada AA, Kawahara S, et al. (2002): Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 109: 851-857.
18. Ness T, Pelz K, &, Hansen LL, (2007): Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand 85: 852-856.
19. Sakai J, Matsuzawa S, Usui M, &, Yano I, (2002): New diagnostic approach for ocular tuberculosis by ELISA using the cord factor as antigen. Br J Ophthalmol 86: 1076-1079.
20. Tabbara KF, (2005): Ocular tuberculosis: anterior segment. Int Ophthalmol Clin 45: 57-69.
21. Tabbara KF, (2007): Tuberculosis. Curr Opin Ophthalmol 18: 493-501.
22. WHO (2008): Global Tuberculosis Control Surveillance, Planning, Financing. WHO Report 2008. Geneva: World Health Organization, Report No. WHO/HTM 393.